Variant report
Variant | esv2203926 |
---|---|
Chromosome Location | chr2:49561297-49561817 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs530600796 | chr2:49561307-49561308 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs187750878 | chr2:49561321-49561322 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs529971919 | chr2:49561331-49561332 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546671910 | chr2:49561335-49561336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs192373628 | chr2:49561342-49561343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs535444606 | chr2:49561365-49561366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs550129194 | chr2:49561366-49561367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs78151732 | chr2:49561394-49561395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs534082539 | chr2:49561603-49561604 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs555839633 | chr2:49561660-49561661 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563831516 | chr2:49561687-49561688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574015027 | chr2:49561699-49561700 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs544615464 | chr2:49561709-49561710 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs77686455 | chr2:49561711-49561712 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs575645190 | chr2:49561718-49561719 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs2098988 | chr2:49561747-49561748 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs564321067 | chr2:49561756-49561757 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183201082 | chr2:49561757-49561758 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs561057601 | chr2:49561780-49561781 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs188083754 | chr2:49561791-49561792 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs561838987 | chr2:49561809-49561810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:49561200-49561400 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr2:49561600-49561800 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr2:49561600-49562800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |